Navigation Links
GlaxoSmithKline Confirms Receipt of FDA Letter on Regulatory Reporting
Date:4/8/2008

LONDON and PHILADELPHIA, April 8, 2008 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today confirmed it has received a warning letter from the US Food and Drug Administration (FDA) related to reporting requirements for approved medicines. The letter follows a routine FDA inspection of GSK's reporting processes conducted last year.

The observations from the inspection primarily relate to omissions from periodic reports to the FDA regarding Avandia(R) (rosiglitazone maleate), such as the start and progress of clinical trials, and summaries of final data from some clinical trials.

The FDA inspection also reviewed GSK's processes for reporting individual adverse events, which resulted in no inspection citations. The inspection found nothing to suggest that procedures for prompt reporting of adverse events was compromised.

"We take these findings seriously, and corrective steps to make sure we file periodic reports completely and promptly have been taken or are underway," said Dr. Ronald Krall, Chief Medical Officer at GlaxoSmithKline. "These omissions did not interfere with the timely reporting of adverse event information to the FDA."

GSK is committed to taking the appropriate steps to address the concerns raised by the FDA.

After the inspection, GSK initiated a review of applicable processes and reporting systems. The company has made and will continue progress in updating its procedures and improving compliance in this area of reporting, including additional training for employees to ensure that all procedures are followed across all product lines.

The FDA letter acknowledges that information not captured in the periodic reports was, in many cases, submitted to the Agency in other reports an
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
9. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
10. GlaxoSmithKline Presents Innovative Neuroscience Pipeline
11. GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , ... September 02, 2015 , ... The medical waste ... billion in 2015, at a CAGR of 5.2%. The global medical waste management market ... The treatment and disposal segment is expected to register the highest growth rate in ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... academic partnership has earned international recognition as a premier center for treatment of ... cause sudden, catastrophic internal bleeding and stroke. , Cure HHT, previously known ...
(Date:9/2/2015)... ... September 02, 2015 , ... Since 2011, DoMyOwnPestControl.com has ... to help support childhood cancer research. On June 17, 2014, the owners ... , which is the fund-raising event DoMyOwnPestControl.com sponsors each year. The very next ...
(Date:9/2/2015)... ... September 02, 2015 , ... A third party ... action after seeing a significant increase in unlawful tactics used by out-of-network (OON) ... many cases of OON ASCs encouraging members to have elective procedures done at ...
(Date:9/2/2015)... ... 02, 2015 , ... A recent survey by Consumer Reports ( http://bit.ly/1h67tL8 ) ... negative impact on consumers. It was reported that 33% are paying an average of ... as an extra $100 compared to last year. Among the drugs that saw the ...
Breaking Medicine News(10 mins):Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 2Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 3Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 4Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 5Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 3Health News:Watertree Health President Responds to Consumer Reports Survey on Rising Prescription Drug Prices 2
... ,Renovis, Inc. (Nasdaq: RNVS ), a biopharmaceutical ... for major medical needs in the areas of,neurological ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, ... Trade Commission,requesting additional information with regard to the ...
... a lifetime, researchers say, , , THURSDAY, April 3 (HealthDay News) ... victims of maltreatment in 2006 during their first year of ... their first week of life, federal officials reported Thursday. ... risk for nonfatal maltreatment of children less than 1 year ...
... scientists are the first to observe in living cells a ... of the four building blocks that comprise DNA. Also ... replication. The findings, which will be published in the ... to new cancer treatments that prevent cancer cells from replicating ...
... of health care information to,patients for disease management, ... Today URAC called,for public comment on revisions ... accreditation programs. URAC is seeking input from any,interested ... organizations and health plans. The deadline for public,comment ...
... 2008 ... WHO/ WHAT: "Iron Andy" Holder, an Ironman Arizona competitor who was ... this Sunday,s triathlon to encourage others who have chronic ... condition and to live without limits., ...
... 3, 2008 -- A study led by researchers at Memorial ... a particular type of molecule to promote metastasis -- the ... 90 percent of all cancer-related deaths. The study is published ... work examines how cells in the body communicate with each ...
Cached Medicine News:Health News:Renovis Announces Expiration of Hart-Scott-Rodino (HSR) 30-Day Waiting Period; Merger With Evotec on Track to Close in Early May, 2008 2Health News:Renovis Announces Expiration of Hart-Scott-Rodino (HSR) 30-Day Waiting Period; Merger With Evotec on Track to Close in Early May, 2008 3Health News:Renovis Announces Expiration of Hart-Scott-Rodino (HSR) 30-Day Waiting Period; Merger With Evotec on Track to Close in Early May, 2008 4Health News:More Than 90,000 U.S. Infants Are Victims of Abuse or Neglect 2Health News:More Than 90,000 U.S. Infants Are Victims of Abuse or Neglect 3Health News:Enzyme complex could be key to new cancer treatments 2Health News:URAC Releases Draft Standards for Public Input for Nine Health Care Management Accreditation Programs 2Health News:Ironman Competitor with Diabetes Encourages Others to Live Without Limits; Competes in Ironman Arizona in Tempe 2Health News:Researchers learn how signaling molecule orchestrates breast cancer's spread 2
(Date:9/2/2015)... -- Demers Ambulances is proud to announce it has signed ... the states of Mississippi , ... "This will enable Demers to effectively meet the ... Vice-President for Demers Ambulances. "Emergency Equipment Professionals has three service ... Alabama , giving them a strategic advantage. Local ...
(Date:9/2/2015)... Sept. 2, 2015  Boca Raton Regional Hospital,s ... begun performing ultra-minimally invasive left atrial appendage ligation ... such as Coumadin, Xarelto or Effient. Dr. Cartledge, ... Hospital, is one of a select group of ... two microscopic incisions in order to seal off ...
(Date:9/2/2015)... 2, 2015  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... will be presenting at the Rodman & Renshaw 17th Annual ... at 9:35 a.m. ET on Thursday, September 10, 2015. ... public via live audio webcast which can be accessed by ... at http://www.aethlonmedical.com . The webcast will be archived for ...
Breaking Medicine Technology:Demers Ambulances has named Emergency Equipment Professionals (EEP) Inc. as their dealer for the states of MS, AL and TN 2Boca Regional Introduces Ultra-Minimally Invasive Surgical Procedure for Atrial Fibrillation Patients 2Boca Regional Introduces Ultra-Minimally Invasive Surgical Procedure for Atrial Fibrillation Patients 3
... a developer of Healthcare Technology Networks ("HTN") designed to ... today announces the launch of its proprietary Opioid Management ... United States Bone & Joint Decade , ... suffering from musculoskeletal disease filled 1.6 billion prescriptions. While ...
... SPRING, Md., April 6, 2012 Sunpeaks Ventures, ... "Sunpeaks Ventures") and its wholly owned subsidiary Healthcare Distribution ... has entered into a sponsorship agreement ("Agreement") with a ... Clotamin, including advertising, media, and promotional elements. The Agreement ...
Cached Medicine Technology:Med-Tek Launches the First Evidenced Based Opioid Management Program (OMP) 2Sunpeaks Ventures Inks Sponsorship and Marketing Agreement with Major Sports Team, Clotamin To Be Sold at Walgreens Locations Throughout Oregon and Southern Washington 2Sunpeaks Ventures Inks Sponsorship and Marketing Agreement with Major Sports Team, Clotamin To Be Sold at Walgreens Locations Throughout Oregon and Southern Washington 3
Alvis foreign body spud 4 3/4 inches, oval curette 1 x 3 mm with fine point....
... is made from MMA/VP material and has a ... is supplied with the base curve and total ... is available in a power range of -30.00DS ... of protective and therapeutic applications including the controlled ...
... soft contact lenses can be used as ... to relieve corneal pain in the treaent ... as bullous keratopathy, corneal erosions, entropion, corneal ... post-surgical conditions resulting from cataract extraction and ...
Cottle-Joseph Double Hook 12 mm wide....
Medicine Products: